Several District 2 Public Health Covid-19 Testing Sites Set to Close

GAINESVILLE –District 2 Public Health, Mako Labs and LTS are making changes to COVID-19 testing site operations; however, the fight against COVID-19 is not over.  District 2 Public Health will continue to provide COVID vaccines at all 13 county health departments on a walk-in basis. 

It is not too late to get a COVID-19 vaccine or booster if eligible.  Everyone 5 and older can be fully vaccinated against COVID-19.  To learn more about COVID-19 visit phdistrict2.org.

The following testing sites will close:

Franklin County Health Department – Last day in operation is April 21

Lumpkin County Health Department – Last day in operation is April 21

Habersham Medical Center – Last day in operation is April 21

Stephens County Hospital – Last day in operation is April 22

NGHS Braselton – Last day in operation is April 22

Rabun Community Market – Last day in operation is April 22

The following testing sites will remain open:

Forsyth County – Central Park Recreation Complex

2300 Keith Bridge Rd., Cumming, GA 30040

Hall County – Sherwood Plaza

601 S. Enota Dr. NE, Gainesville, GA 30501

Union County – Union General Hospital

35 Hospital Road, Blairsville, GA 30512

#####

FDA Authorizes Covid-19 Pre-Exposure Prevention for Certain Individuals

GAINESVILLE – The Food and Drug Administration issued an emergency use authorization (EUA) for the first injectable monoclonal antibody medication for pre-exposure prevention of COVID-19 for certain adults and pediatric individuals (12 years and older).

The pre-exposure therapy, Evusheld by AstraZeneca, is authorized for those individuals who are not currently infected with the SARS-CoV-2 virus and who have not recently been exposed to an individual infected with SARS-CoV-2. The authorization also requires that individuals either have:

  • moderate to severely compromised immune systems due to a medical condition or due to taking immunosuppressive medications or treatments and may not mount an adequate immune response to COVID-19 vaccination (examples of such medical conditions or treatments can be found in the fact sheet for health care providers) or;
  • a history of severe adverse reactions to a COVID-19 vaccine and/or component(s) of those vaccines, therefore vaccination with an available COVID-19 vaccine, according to the approved or authorized schedule, is not recommended.

“Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune compromised individuals who may not mount an adequate immune response to COVID-19 vaccination, or those who have a history of severe adverse reactions to a COVID-19 vaccine and therefore cannot receive one and need an alternative prevention option,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Today’s action authorizes the use of the combination of two monoclonal antibodies to reduce the risk of developing COVID-19 in these individuals.”

To learn more about the pre-exposure monoclonal antibody therapy, speak with your physician or visit the District 2 Public Health website.